TradingView
rmcnally11
24 nov 2023 16:13

Low downside  Long

NASDAQ:BLUE1D
bluebird bio, Inc.NASDAQ

Descrizione

⋅

Asymmetric upside here on a biotech stock that's been absolutely battered. Runway for pharmaceutical approvals are ripe and Dec 20 could launch this.
Fundamental AnalysisBeyond Technical Analysis
Altro